05004nam 22007455 450 991087879000332120240923115432.03-031-62301-010.1007/978-3-031-62301-1(CKB)33601079800041(MiAaPQ)EBC31594172(Au-PeEL)EBL31594172(DE-He213)978-3-031-62301-1(EXLCZ)993360107980004120240724d2025 u| 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierPrimary Adrenal Malignancies /edited by Guido A. M. Tiberio1st ed. 2025.Cham :Springer Nature Switzerland :Imprint: Springer,2025.1 online resource (177 pages)Updates in Surgery,2281-08543-031-62300-2 1. Epidemiology, Presentation, Staging, and Prognostic Factors in Adrenocortical Carcinoma -- 2. Epidemiology, Presentation, Staging, and Prognostic Factors in Malignant Pheochromocytoma -- 3. Genetics and Molecular Biology of Adrenocortical Carcinoma -- 4. Genetics and Molecular Biology of Pheochromocytoma and Paraganglioma -- 5. Imaging in Adrenocortical Carcinoma and Malignant Pheochromocytoma -- 6. Management of Endocrine Syndromes Associated with Adrenocortical Carcinoma -- 7. Management of Hereditary Syndromes Associated with Pheochromocytoma/Paraganglioma -- 8. Adrenal Incidentaloma -- 9. Surgery for Adrenocortical Carcinoma -- 10. Adrenocortical Carcinoma with Vena Cava Involvement -- 11. Adrenocortical Carcinoma: the Posterior Minimally Invasive Approach -- 12. Surgery for Malignant Pheochromocytoma -- 13. Open or Laparoscopic Surgery in the Management of Adrenocortical Carcinoma? -- 14. Pathology of Adrenocortical Carcinoma and Malignant Pheochromocytoma -- 15. Medical Treatment in Advanced Adrenocortical Carcinoma -- 16. Integrated Approach in Locally Advanced, Oligometastatic or Recurrent Adrenocortical Carcinoma -- 17. Medical Treatment of Malignant Pheochromocytoma -- 18. Role of Radiotherapy in Adrenocortical Carcinoma and Pheochromocytoma -- 19. Radionuclide Treatment in Malignant Pheochromocytoma -- 20. Preclinic and Translational Research in Adrenal Malignancies.Dissemination of knowledge is the best and only strategy capable of improving clinical management in rare and ultra-rare malignancies, including primary adrenal malignancies. It is preliminary to any further healthcare policy such as, for example, the centralization of cases in referral institutions. Adrenal primary malignancies are probably the rarest among rare pathologies. This epidemiological consideration is at the origin of a vicious circle: the lack of preoperative diagnosis leads to inappropriate surgical procedures and to inadequate follow-up and systemic therapy strategies. Furthermore, when malignancy is recognized, the relative role of systemic, surgical, or other local ablative techniques is often misinterpreted. All this produces a negative impact on survival, also in patients who could have been cured with a correct therapeutic strategy. This open access book provides a user-friendly exploration of these rare conditions, using a transversal approach common in modern precision medicine. The text covers various clinical aspects, including epidemiology, genetics, molecular medicine, imaging, and surgery. Guidelines for managing syndromic situations are provided. The book thoroughly addresses all the different surgical issues and emphasizes the importance of pathology in assessing prognosis. The pivotal role of medical oncologists in managing these patients is explored, along with alternative treatments such as nuclear medicine and radiotherapy. Finally, the book highlights the latest preclinical research and its implications for translational medicine.Updates in Surgery,2281-0854SurgeryInternal medicineGeneticsRadiologyOncologyMedicineResearchBiologyResearchGeneral SurgeryInternal MedicineGeneticsRadiologyOncologyTranslational ResearchSurgery.Internal medicine.Genetics.Radiology.Oncology.MedicineResearch.BiologyResearch.General Surgery.Internal Medicine.Genetics.Radiology.Oncology.Translational Research.617Tiberio Guido A. M1764635Tiberio1764636MiAaPQMiAaPQMiAaPQBOOK9910878790003321Primary Adrenal Malignancies4205643UNINA